Skip to main content
HighlightsHighlights Archive

Media Monitoring: 4 – 10 April

By April 10, 2024No Comments

NHS expands ‘one-hour’ liver testing to help detect and eliminate Hep C

  • Thousands of people unknowingly living with hepatitis C are to be identified, diagnosed and cured thanks to major NHS investment in rapid testing technology
  • New liver scanning and portable testing units will be deployed in a range of communities where patients are at high risk of contracting the infection
  • Thirty-four Cepheid GeneXpert portable testing units will also be procured and expanded to community settings including GP clinics and prisons, to allow the elimination programme’s teams to test people experiencing homelessness or drug users who may struggle to meet appointments

 

Scientists identify gene variants linked to obesity risk

  • A study led by MRC researchers has identified genetic variants in two genes that have some of the largest impacts on obesity risk discovered to date
  • The discovery of rare variants in the genes ‘BSN’ and ‘APBA1’ are some of the first obesity-related genes identified for which the increased risk of obesity is not observed until adulthood
  • The researchers used UK Biobank and other data to perform whole exome sequencing of body mass index (BMI) in over 500,000 individuals

 

Limited innovation and profitability driving slow motion AMR crisis

  • Professor Peter Piot, Belgium’s special advisor to European Commission president Ursula von der Leyen for European and Global Health Security, has called antimicrobial resistance (AMR) a crisis already underway and gaining importance
  • Piot was speaking at the recent High-Level Conference on the Future EU Health Union organised by the Belgian Presidency, “AMR causes one million deaths annually, and we must address it,” he said
  • In Belgium, the effects of antibiotic resistance are also increasingly felt. According to Sciensano, 7% of hospitalised patients are infected with resistant bacteria. This alone leads to some 2,600 deaths per year

 

EIT Health supported consortium myEDIT-B launches blood test that can differentiate bipolar disorder from depression

  • EIT Health has announced the launch of consortium myEDIT-B’s new blood diagnostic test in France to differentiate between depression and bipolar disorder
  • The test was launched on March 30, 2024, to mark World Bipolar Day

 

Using AI to develop diagnostic technologies

  • Lorna Rothery spoke to co-developer Dr Nicole Robb about how novel diagnostic technologies could improve healthcare delivery

 

Making the future a reality: harnessing the potential of patient-facing tech in healthcare

  • A guide of practical actions to realise the potential of patient technology in healthcare

 

London stock market is ‘going down the gurgler’, warns industry veteran (paywall)

 

 

Ben Kemp